Cancer researchers have long known that prostate cancer tends to be more common, more aggressive and more resistant to existing treatments in African Americans than in Caucasian Americans, but they’re only beginning to understand why.
At a time when federal immigration policies are becoming stricter, Kunle Odunsi, director of University of Chicago Medicine Comprehensive Cancer Center, reflected on the fact that cancer research is a highly international community.
